The United States Insulin Delivery Devices Market is expected to surpass US$ 10 billion by 2027.
This new report offerings an in-depth assessment of the U.S insulin delivery devices market dynamics, opportunities, future road-map, competitive landscape and discusses major trends. The report presents the most up-to-date industry data on the actual and potential market situation and future outlook for insulin delivery devices in the United States. The report also provides up–to–date historical market size data for the period 2019 – 2020 and an illustrative forecast to 2027 covering key market aspects like market value and volume for insulin delivery devices in the United States.
The United States insulin delivery devices market is one of the high – growth evolving industries with potential opportunities throughout 2027. The report delivers an all-around analysis of the overall number of patients with diabetes in the United States. Moreover, the report provides deep insights on type 1, type 2, and newly diagnosed type 1 diabetes patients’ data.
Additionally, this report provides overall insulin delivery devices users insights and up-to-date market size with more focused on their product categories such as Insulin Pump, Insulin Pen, Insulin Syringe, Insulin Inhaler, and Insulin Jet Injector.
Additionally, this up-to-date market report describes the latest features reimbursement pattern and offers a clear view of the regulatory framework of the United States insulin delivery devices market. Key trends in terms of collaboration, partnership deals, licensing, and exclusive agreement are analyzed in detail. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the U.S insulin delivery devices market.
The report also analyses detailed profiles of innovative and leading players with information on business overview, product portfolio, and the latest developments.
The United States Insulin Delivery Devices Market Segmentation, by Products
• Insulin Pump
• Insulin Pen
o Reusable Insulin Pen
o Prefilled Insulin Pen
o Smart Insulin Pen
• Insulin Syringe
• Insulin Inhaler
• Insulin Jet Injector
This Comprehensive Market Research Report Provides:
• The Market Size of the United States Insulin Delivery Devices with Six Years Forecast
• The United States Insulin Delivery Devices Market Share and Y-o-Y Growth (%), 2019 – 2027
• The Market Size of the United States Insulin Pump Market with Six Years Forecast
• The Market Size of the United States Insulin Pen Market with Six Years Forecast
• The Market Size of the United States Reusable Insulin Pen with Six Years Forecast
• The Market Size of the United States Prefilled Insulin Pen with Six Years Forecast
• The Market Size of the United States Smart Insulin Pen with Six Years Forecast
• The United States Insulin Pen Market Share and Y-o-Y Growth (%), 2019 – 2027
• The Market Size of the United States Insulin Inhaler with Six Years Forecast
• The Market Size of the United States Insulin Syringe with Six Years Forecast
• The Market Size of the United States Insulin Jet Injector with Six Years Forecast
• Detailed Insights of the Overall United States Insulin Delivery Devices Users Volume and Forecast to 2027
• Meticulously Assesses of the United States Insulin Pump Users Volume with Six Years Forecast
• Inspects the United States Insulin Pen Users Volume with Six Years Forecast
• Analyzes the United States Reusable Insulin Pen Users Volume with Six Years Forecast
• Studies the United States Prefilled Insulin Pen Users Volume with Six Years Forecast
• Investigates the United States Smart Insulin Pen Users Volume with Six Years Forecast
• Explores the United States Insulin Syringe Users Volume with Six Years Forecast
• Examines the United States Insulin Inhaler Users Volume with Six Years Forecast
• Scrutinizes of the United States Insulin Jet Injector Users Volume with Six Years Forecast
• Detailed Insights into the Regulatory Framework of the United States Insulin Delivery Devices Market
• Features Reimbursement Patterns of the United States Insulin Delivery Devices Market
• Delivers an In-Depth Analysis of Evolving Market Trends, Drivers and Restraints of the United States Insulin Delivery Devices Market
• Tracks Competitive Developments, Approaches, Recent Industry Developments, Collaboration Deals, Partnership Deals, Licensing and Exclusive Agreement.
• A Comprehensive List of the Key Players Along with the Analysis of their Current Product Portfolios, Business Overview, and Latest Development
The Leading Companies for the United States Insulin Delivery Devices Market are Listed Below:
• Medtronic
• Tandem Diabetes Care
• Insulet Corporation
• Sooil Development
• Novo Nordisk
• Eli Lilly and Company
• Sanofi
• Owen Mumford
• Companion Medical
• Diabnext
• Digital Medics Ptd Ltd.
• Emperra GmbH E-Health Technologies
• Diamesco Co., Ltd.
• Becton, Dickinson, and Company (BD)
• Abbott Diabetes Care
• Smith’s Medical, Inc.
• Arkray, Inc
• Trividia Health, Inc
• MHC Medical Products, LLC
• Home Aide Diagnostics, Inc
• Advocate Meters (Pharma Supply, Inc.)
• Retractable Technologies, Inc.
• Prodigy Diabetes Care, LLC
• UltiMed, Inc
• AdvaCare Pharma USA, LLC
• Allison Medical, Inc
• Cardinal Health, Inc
• MannKind Corporation
• Insujet
Key Questions Addressed by the Report
• What is the current size of the overall insulin delivery devices market in the United States?
• How much will this market be worth from 2021 to 2027?
• How big is the United States insulin delivery devices market?
• What is the total insulin delivery devices users volume in the United States?
• What are the key marketed insulin delivery devices available in the United States?
• What are the major drivers of the United States insulin delivery devices market?
• What are the major inhibitors of the United States insulin delivery devices market?
• What is the reimbursement pattern of the United States insulin delivery devices market?
• What is the regulatory framework of the United States insulin delivery devices market?
• Which companies make insulin delivery devices?
• Who are the top market players? What are their happenings, current developments, and scenarios?
'
1. Executive Summary
2. United States Diabetes Population (2019 – 2027): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes
3. United States Insulin Delivery Devices Users Analysis (2019 – 2027)
3.1 Overall Insulin Delivery Users Snapshot
3.2 Insulin Pump Users
3.2.1 Type 1 Diabetes Insulin Pump Users
3.2.2 Type 2 Diabetes Insulin Pump Users
3.3 Insulin Pen Users
3.3.1 Reusable (Cartridge) Insulin Pen Users
3.3.2 Prefilled (Disposable) Insulin Pen Users
3.3.3 Smart Insulin Pen Users
3.4 Insulin Pen Segment – (Reusable, Prefilled, Smart Insulin Pen) Users Share
3.5 Insulin Syringe Users
3.6 Insulin Inhaler Users
3.7 Insulin Jet Injector Users
4. United States Insulin Delivery Devices Market Size and Forecast(2019 – 2027)
4.1 Overall Insulin Delivery Devices Market Snapshot
4.2 Insulin Delivery Devices Segment – (Insulin Pump, Insulin Pen, Insulin Syringe, Insulin Inhaler, Insulin Jet Injector) Market Share
4.3 Insulin Pump Market Size
4.4 Insulin Pen Market Size
4.4.1 Reusable (Cartridge) Insulin Pen Market
4.4.2 Prefilled (Disposable) Insulin Pen Market
4.4.3 Smart Insulin Pen Market
4.5 Insulin Pen Segment – (Reusable,Prefilled and Smart Insulin Pen) Market Share
4.6 Insulin Syringe Market Size
4.7 Insulin Inhaler Market Size
4.8 Insulin Jet Injector Market Size
5. Key Market Growth Drivers and Challenges of the United States Insulin Delivery Devices Market
5.1 Market Growth Drivers
5.2 Market Challenges
6. Regulatory Framework of the United States Insulin Delivery Devices Market
7. Reimbursement Environment of the United States Insulin Delivery Devices Market
7.1 Insulin Pump
7.2 Insulin Pen
7.3 Insulin Syringe
7.4 Insulin Inhaler
7.5 Insulin Jet Injector
8. Major Deals Happening in the Insulin Delivery Devices Market
8.1 Collaboration Deals
8.2 Licensing Agreement
8.3 Exclusive Agreement
8.4 Partnerships Deal
9. Key Companies Analysis
9.1 Medtronic
9.1.1 Business Overview
9.1.2 Product Portfolios
9.1.3 Latest Development
9.2 Tandem Diabetes Care
9.2.1 Business Overview
9.2.2 Product Portfolios
9.2.3 Latest Development
9.3 Insulet Corporation
9.3.1 Business Overview
9.3.2 Product Portfolios
9.3.3 Latest Development
9.4 Sooil Development
9.4.1 Business Overview
9.4.2 Product Portfolios
9.4.3 Latest Development
9.5 Novo Nordisk
9.5.1 Business Overview
9.5.2 Product Portfolios
9.5.3 Latest Development
9.6 Eli Lilly and Company
9.6.1 Business Overview
9.6.2 Product Portfolios
9.6.3 Latest Development
9.7 Sanofi
9.7.1 Business Overview
9.7.2 Product Portfolios
9.7.3 Latest Development
9.8 Owen Mumford
9.8.1 Business Overview
9.8.2 Product Portfolios
9.8.3 Recent Development
9.9 Companion Medical
9.9.1 Business Overview
9.9.2 Product Portfolios
9.9.3 Latest Development
9.10 Diabnext
9.10.1 Business Overview
9.10.2 Product Portfolios
9.10.3 Latest Development
9.11 Digital Medics Ptd Ltd.
9.11.1 Business Overview
9.11.2 Product Portfolios
9.11.3 Latest Development
9.12 Emperra GmbH E-Health Technologies
9.12.1 Business Overview
9.12.2 Product Portfolios
9.12.3 Latest Development
9.13 Diamesco Co., Ltd.
9.13.1 Business Overview
9.13.2 Product Portfolios
9.13.3 Latest Development
9.14 Becton, Dickinson, and Company (BD)
9.14.1 Business Overview
9.14.2 Product Portfolios
9.14.3 Latest Development
9.15 Abbott Diabetes Care
9.15.1 Business Overview
9.15.2 Product Portfolios
9.16 Smith’s Medical, Inc.
9.16.1 Business Overview
9.16.2 Product Portfolios
9.17 Arkray, Inc
9.17.1 Business Overview
9.17.2 Product Portfolios
9.18 Trividia Health, Inc
9.18.1 Business Overview
9.18.2 Product Portfolios
9.19 MHC Medical Products, LLC
9.19.1 Business Overview
9.19.2 Product Portfolios
9.20 Home Aide Diagnostics, Inc
9.20.1 Business Overview
9.20.2 Product Portfolios
9.21 Advocate Meters (Pharma Supply, Inc.)
9.21.1 Business Overview
9.21.2 Product Portfolios
9.22 Retractable Technologies, Inc.
9.22.1 Business Overview
9.22.2 Product Portfolios
9.23 Prodigy Diabetes Care, LLC
9.23.1 Business Overview
9.23.2 Product Portfolios
9.24 UltiMed, Inc
9.24.1 Business Overview
9.24.2 Product Portfolios
9.25 AdvaCare Pharma USA, LLC
9.25.1 Business Overview
9.25.2 Product Portfolios
9.26 Allison Medical, Inc
9.26.1 Business Overview
9.26.2 Product Portfolios
9.27 Cardinal Health, Inc
9.27.1 Business Overview
9.27.2 Product Portfolios
9.28 MannKind Corporation
9.28.1 Business Overview
9.28.2 Product Portfolios
9.28.3 Latest Development
9.29 Insujet
9.29.1 Business Overview
9.29.2 Product Portfolios
9.29.3 Latest Development
List of Tables:
Table 3–1: United States Insulin Pen Users Share (Percent),2019 – 2020
Table 3–2: United States Insulin Pen Users Share Forecast (Percent),2021 – 2027
Table 4–1: Insulin Delivery Devices Segment Market Share (Percent),2019 – 2020
Table 4–2: Insulin Delivery Devices Segment Market Share Forecast (Percent),2021 – 2027
Table 4–3: United States Insulin Pen Market Share (Percent),2019 – 2020
Table 4–4: United States Insulin Pen Market Share Forecast (Percent),2021 – 2027
Table 5–1: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
Table 8–1: Collaboration Deals in the Insulin Delivery Devices Market
Table 8–2: Licensing Agreement in the Insulin Delivery Devices Market
Table 8–3: Exclusive Agreement in the Insulin Delivery Devices Market
Table 8–4: Partnerships Deals in the Insulin Delivery Devices Market
List of Figures:
Figure 2–1: United States Overall Diabetes Population (Thousand), 2019 – 2020
Figure 2–2: United States Overall Diabetes Population Forecast (Thousand), 2021 – 2027
Figure 2–3: United States Type 1 Diabetes Population (Thousand), 2019 – 2020
Figure 2–4: United States Type 1 Diabetes Population Forecast (Thousand), 2021 – 2027
Figure 2–5: United States Type 2 Diabetes Population (Thousand), 2019 – 2020
Figure 2–6: United States Type 2 Diabetes Population Forecast (Thousand), 2021 – 2027
Figure 2–7: United States Newly Diagnosed Type 1 Diabetes Population (Number), 2019 – 2020
Figure 2–8: United States Newly Diagnosed Type 1 Diabetes Population Forecast (Number), 2021 – 2027
Figure 3–1: United States Overall Insulin Delivery Users (Thousand),2019 – 2020
Figure 3–2: United States Overall Insulin Delivery Users Forecast (Thousand),2021 – 2027
Figure 3–3: United States Insulin Pump Users (Number), 2019 – 2020
Figure 3–4: United States Insulin Pump Users Forecast (Number), 2021 – 2027
Figure 3–5: United States Type 1 Diabetes Insulin Pump Users (Number), 2019 – 2020
Figure 3–6: United States Type 1 Diabetes Insulin Pump Users Forecast (Number), 2021 – 2027
Figure 3–7: United States Type 2 Diabetes Insulin Pump Users (Number), 2019 – 2020
Figure 3–8: United States Type 2 Diabetes Insulin Pump Users Forecast (Number), 2021 – 2027
Figure 3–9: United States Overall Insulin Pen Users (Thousand), 2019 – 2020
Figure 3–10: United States Overall Insulin Pen Users Forecast (Thousand), 2021 – 2027
Figure 3–11: United States Reusable Insulin Pen Users (Thousand), 2019 – 2020
Figure 3–12: United States Reusable Insulin Pen Users Forecast (Thousand), 2021 – 2027
Figure 3–13: United States Prefilled Insulin Pen Users (Thousand), 2019 – 2020
Figure 3–14: United States Prefilled Insulin Pen Users Forecast (Thousand), 2021 – 2027
Figure 3–15: United States Smart Insulin Pen Users (Thousand), 2019 – 2020
Figure 3–16: United States Smart Insulin Pen Users Forecast (Thousand), 2021 – 2027
Figure 3–17: United States Insulin Syringe Users (Thousand), 2019 – 2020
Figure 3–18: United States Insulin Syringe Users Forecast (Thousand), 2021 – 2027
Figure 3–19: United States Insulin Inhaler Users (Thousand), 2019 – 2020
Figure 3–20: United States Insulin Inhaler Users Forecast (Thousand), 2021 – 2027
Figure 3–21: United States Insulin Jet Injector Users (Thousand), 2019 – 2020
Figure 3–22: United States Insulin Jet Injector Users Forecast (Thousand), 2021 – 2027
Figure 4–1: United States Overall Insulin Delivery Devices Market (Million US$),2019 – 2027
Figure 4–2: United States Overall Insulin Delivery Devices Market Forecast (Million US$),2021 – 2027
Figure 4–3: United States Insulin Pump Market (Million US$), 2019 – 2020
Figure 4–4: United States Insulin Pump Market Forecast (Million US$), 2021 – 2027
Figure 4–5: United States Insulin Pen Market (Million US$), 2019 – 2020
Figure 4–6: United States Insulin Pen Market Forecast (Million US$), 2021 – 2027
Figure 4–7: United States Reusable Insulin Pen Market (Million US$), 2019 – 2020
Figure 4–8: United States Reusable Insulin Pen Market Forecast (Million US$), 2021 – 2027
Figure 4–9: United States Prefilled Insulin Pen Market (Million US$), 2019 – 2020
Figure 4–10: United States Prefilled Insulin Pen Market Forecast (Million US$), 2021 – 2027
Figure 4–11: United States Smart Insulin Pen Market (Million US$), 2019 – 2020
Figure 4–12: United States Smart Insulin Pen Market Forecast (Million US$), 2021 – 2027
Figure 4–13: United States Insulin Syringe Market (Million US$), 2019 – 2020
Figure 4–14: United States Insulin Syringe Market Forecast (Million US$), 2021 – 2027
Figure 4–15: United States Insulin Inhaler Market (Million US$), 2019 – 2020
Figure 4–16: United States Insulin Inhaler Market Forecast (Million US$), 2021 – 2027
Figure 4–17: United States Insulin Injector Market (Million US$), 2019 – 2020
Figure 4–18: United States Insulin Injector Market Forecast (Million US$), 2021 – 2027
